TITLE

SEX HORMONAL STATUS EFFECTS MEAL STIMULATED PLASMA 5-HYDROXYTRYPTAMINE (5-HT) LEVELS IN FEMALE PATIENTS WITH DIARRHOEA PREDOMINANT IRRITABLE BOWEL SYNDROME (D-IBS)

AUTHOR(S)
Atkinson, W.; Houghton, L.A.; Whorwell, P.J.; Whitaker, P.
PUB. DATE
April 2003
SOURCE
Gut;Apr2003 Supplement 1, Vol. 52, pA38
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
We have previously shown that 5-HT may play a role in the post-prandial exacerbation of symptoms seen in female patients with d-lBS. As both progesterone (P) and oestrogen (O) can influence the 5-HT system, the aim of th s study was to compare plasma 5-HT concentrations in female patients with d-lBS (Rome II) with high and ow levels of P/O. Platelet depleted plasma (PDP) 5-HT concentration was therefore assessed for 2 h (60 min intervals) under fasting conditions and 4 h (30 min intervals) after a standard carbohydrate meal (457 kcal) in 39 patients (aged 19-52 yrs) with high P/O (studied either during the luteal phase of the menstrual cycle or while taking combined P/O oral contraception) and in 11 aged matched patients (aged 22-45 years) with Iow P/O levels (menses). 5-HT concentration was measured by reverse-phase high performance liquid chromatography with fluorimetric detection. In addition, symptomatology (0-4; 4 = severe) was assessed throughout the study. Results: Under fasting conditions there was no difference in PDP 5-HT concentration between patients with a high (5.41 ng/ml, (mean)) and Iow (4.98 ng/ml; difference high Iow (95%CI), 0.43 ng/ml (-0.69,1.55) ng/ml; p = 0.443) P/O status. Following meal ingestion, however, patients with high P/O levels have a significantly higher PDP 5-HT peak (13.99 ng/ml; (geometric mean) than those with Iow P/O levels (8.57 ng/ml; ratio high:low, 1.63 (1.02,2.62); p = 0.043). This difference was particularly evident in patients reporting post-prandial symptoms (patients with high P/O levels (n = 31): 15.60 ng/ml v patients with Iow P/O levels (n = 11): 8.57 ng/ml; ratio high:low, 1.82 (1.12, 2.96); p = 0.017) and was not related to a difference in symptom severity between the two groups (patients with high P/O levels: 0.70 (mean) v Iow P/E levels: 0.58; difference highIow, 0.12 (-0.28, 0.53); p = 0.547. Conclusions: Female sex hormones may play a role in the gastrointestinal tract 5-HT response to a meal in female...
ACCESSION #
9747522

 

Related Articles

  • Preliminary array analysis reveals novel genes regulated by ovarian steroids in the monkey raphe region. Reddy, Arubala P.; Bethea, Cynthia L. // Psychopharmacology;Jun2005, Vol. 180 Issue 1, p125 

    We hypothesize that ovarian hormones may improve serotonin neuron survival. We sought the effect of estradiol (E) and progesterone (P) on novel gene expression in the macaque dorsal raphe region with Affymetrix array analysis. Nine spayed rhesus macaques were treated with either placebo, E or...

  • Ovarian Steroid Treatment Decreases Corticotropin-Releasing Hormone (CRH) mRNA and Protein in the Hypothalamic Paraventricular Nucleus of Ovariectomized Monkeys. Bethea, Cynthia L.; Centeno, Maria Luisa // Neuropsychopharmacology;Feb2008, Vol. 33 Issue 3, p546 

    Corticotropin-releasing hormone (CRH) gene and protein expression were examined in the paraventricular nucleus (PVN) of ovariectomized female macaques treated with placebo or hormone therapy (HT) consisting of either estrogen (E) for 28 days, or progesterone (P) for the last 14 of 28 days, or E...

  • Estrogen and progesterone distinctively modulate methamphetamine-induced dopamine and serotonin depletions in C57BL/6J mice. Yu, L.; Liao, P.-C. // Journal of Neural Transmission;Oct2000, Vol. 107 Issue 10, p1139 

    Summary. Intra-striatal infusion of a high dose (100 μg/3 μl) of methamphetamine produced long-lasting depletions of striatal dopamine and serotonin in both male and female mice. Male mice exhibited a greater depletion of striatal dopamine and serotonin than female mice. A similar trend of...

  • is it just the baby blues? Cohen, Marisa // Baby Talk;Jun/Jul2009, Vol. 74 Issue 5, p56 

    The article presents information on postpartum depression (PPD) among new mothers. This is a mood disorder in which a mother feels sad, moody, or irritable. It is stated that the condition is caused due to hormone shifts, and can affect nearly 50 to 80 percent of new mothers. According to...

  • Your Period and Your Health.  // Redbook;Oct99, Vol. 193 Issue 5, p27 

    Discusses the effects of fluctuating levels of progesterone and estrogen on the specialized cells of the human body's immune system.

  • PMS in the perimenopause. Hassan, Ismail; Ismail, Khaled MK; O'Brien, Shaughn // Journal of the British Menopause Society;2004, Vol. 10 Issue 4, p151 

    Premenstrual syndrome (PMS) and the perimenopause are each difficult conditions to manage. When they co-exist the difficulty is more than doubled. Understanding and recognising the differences and the similarities between these conditions should enable clinicians to provide appropriate treatment...

  • Serum Levels of Tryptophan, 5-Hydroxytryptophan and Serotonin in Patients Affected with Different Forms of Amenorrhea. Comai, S.; Bertazzo, A.; Carretti, N.; Podfigurna-Stopa, A.; Luisi, S.; Costa, C. V. L. // International Journal of Tryptophan Research;2010, Issue 3, p69 

    Tryptophan (Trp) is present in the serum, partly bound to albumine and in the free form. The unbound portion of circulating tryptophan has the property of crossing the hematoencephalic barrier and being converted within the brain into serotonin (5-HT) through the enzymatic processes of...

  • Young woman, old bones.  // Joe Weider's Muscle & Fitness;May96, Vol. 57 Issue 5, p27 

    Reports on the use of estrogen and progesterone for treatment in health problems of young female athletes. Information on use of estrogen and progesterone; Description of their success; Views from W.O. Roberts from the Physician and Sportsmedicine.

  • Pharmacokinetics of Etonogestrel and Ethinylestradiol Released from a Combined Contraceptive Vaginal Ring. Timmer, C.J.; Mulders, T.M.T. // Clinical Pharmacokinetics;2000, Vol. 39 Issue 3, p233 

    Objective: To assess the pharmacokinetics of etonogestrel and ethinylestradiol released from a novel combined contraceptive vaginal ring (NuvaRing) releasing etonogestrel 120µg and ethinylestradiol 15µg per day and compare them with those of a combined oral contraceptive containing...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics